Identification of Serum MicroRNA Biomarkers for Tuberculosis Using RNA-seq

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Mar 4

PMID 24586438

Citations 43

Authors

Hongtai Zhang

Zhaogang Sun

Wenjing Wei

Zhonghui Liu

Joy Fleming

Shuai Zhang

Nan Lin

Ming Wang

Maoshan Chen

Yuhui Xu

Jie Zhou

Chuanyou Li

Lijun Bi

Guangming Zhou

Affiliations

Soon will be listed here.

Abstract

Tuberculosis (TB) remains a significant human health issue. More effective biomarkers for use in tuberculosis prevention, diagnosis, and treatment, including markers that can discriminate between healthy individuals and those with latent infection, are urgently needed. To identify a set of such markers, we used Solexa sequencing to examine microRNA expression in the serum of patients with active disease, healthy individuals with latent TB, and those with or without prior BCG inoculation. We identified 24 microRNAs that are up-regulated (2.85-1285.93 fold) and 6 microRNAs that are down-regulated (0.003-0.11 fold) (P<0.05) in patients with active TB relative to the three groups of healthy controls. In addition, 75 microRNAs were up-regulated (2.05-2454.58 fold) and 11 were down-regulated (0.001-0.42 fold) (P<0.05) in latent-TB infected individuals relative to BCG- inoculated individuals. Of interest, 134 microRNAs were differentially-expressed in BCG-inoculated relative to un-inoculated individuals (18 up-regulated 2.9-499.29 fold, 116 down-regulated 0.0002-0.5 fold), providing insights into the effects of BCG inoculation at the microRNA level. Target prediction of differentially-expressed microRNAs by microRNA-Gene Network analysis and analysis of pathways affected suggest that regulation of the host immune system by microRNAs is likely to be one of the main factors in the pathogenesis of tuberculosis. qRT-PCR validation indicated that hsa-miR-196b and hsa-miR-376c have potential as markers for active TB disease. The microRNA differential-expression profiles generated in this study provide a good foundation for the development of markers for TB diagnosis, and for investigations on the role of microRNAs in BCG-inoculated and latent-infected individuals.

Citing Articles

Construction of circRNA-miRNA-mRNA ceRNA regulatory network and screening of diagnostic targets for tuberculosis.

Pu X, Sheng S, Fu Y, Yang Y, Xu G Ann Med. 2024; 56(1):2416604.

PMID: 39435612 PMC: 11497567. DOI: 10.1080/07853890.2024.2416604.

Single molecule measurements of microRNAs in the serum of patients with pulmonary tuberculosis.

Wu Z, Tan Q, Jia X, Wu H, Liang J, Wen W Front Immunol. 2024; 15:1418085.

PMID: 39286248 PMC: 11402676. DOI: 10.3389/fimmu.2024.1418085.

Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review.

Leo S, Narasimhan M, Rathinam S, Banerjee A Ann Med. 2024; 56(1):2386030.

PMID: 39097795 PMC: 11299445. DOI: 10.1080/07853890.2024.2386030.

Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis.

Sampath P, Moorthy M, Menon A, Madhav L, Janaki A, Dhanapal M Front Immunol. 2023; 14:1197805.

PMID: 37457712 PMC: 10345223. DOI: 10.3389/fimmu.2023.1197805.

MicroRNAs as immune regulators and biomarkers in tuberculosis.

Wang L, Xiong Y, Fu B, Guo D, Zaky M, Lin X Front Immunol. 2022; 13:1027472.

PMID: 36389769 PMC: 9647078. DOI: 10.3389/fimmu.2022.1027472.

References

Guo J, Dong Q, Fang Z, Chen X, Lu H, Wang K . Identification of miRNAs that are associated with tumor metastasis in neuroblastoma. Cancer Biol Ther. 2010; 9(6):446-52. DOI: 10.4161/cbt.9.6.10894. View

Oh H, Tan A, Das K, Ooi C, Deng N, Tan I . Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res. 2011; 17(9):2657-67. DOI: 10.1158/1078-0432.CCR-10-3152. View

Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M, Narahara H . miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod. 2013; 28(3):750-61. DOI: 10.1093/humrep/des446. View

Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M . The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol. 2011; 12(9):861-9. DOI: 10.1038/ni.2073. View

Ciafre S, Galardi S, Mangiola A, Ferracin M, Liu C, Sabatino G . Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005; 334(4):1351-8. DOI: 10.1016/j.bbrc.2005.07.030. View

Arias Guillen M . Advances in the diagnosis of tuberculosis infection. Arch Bronconeumol. 2011; 47(10):521-30. DOI: 10.1016/j.arbres.2011.06.018. View

Cawood R, Chen H, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour L . Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 2009; 5(5):e1000440. PMC: 2678247. DOI: 10.1371/journal.ppat.1000440. View

Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C . A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res. 2011; 17(21):6802-11. DOI: 10.1158/1078-0432.CCR-11-0419. View

Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O . Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005; 37(7):766-70. DOI: 10.1038/ng1590. View

10.

Sylvius N, Bonne G, Straatman K, Reddy T, Gant T, Shackleton S . MicroRNA expression profiling in patients with lamin A/C-associated muscular dystrophy. FASEB J. 2011; 25(11):3966-78. DOI: 10.1096/fj.11-182915. View

11.

Krichevsky A, King K, Donahue C, Khrapko K, Kosik K . A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003; 9(10):1274-81. PMC: 1370491. DOI: 10.1261/rna.5980303. View

12.

Fu Y, Yi Z, Wu X, Li J, Xu F . Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol. 2011; 49(12):4246-51. PMC: 3232949. DOI: 10.1128/JCM.05459-11. View

13.

Liu C, Calin G, Meloon B, Gamliel N, Sevignani C, Ferracin M . An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A. 2004; 101(26):9740-4. PMC: 470744. DOI: 10.1073/pnas.0403293101. View

14.

Ng E, Li R, Shin V, Jin H, Leung C, Ma E . Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One. 2013; 8(1):e53141. PMC: 3536802. DOI: 10.1371/journal.pone.0053141. View

15.

Lee J, Kim M, Im Y, Choi W, Byeon S, Lee H . NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci. 2008; 49(5):1827-35. DOI: 10.1167/iovs.07-1142. View

16.

Schmittgen T, Jiang J, Liu Q, Yang L . A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004; 32(4):e43. PMC: 390315. DOI: 10.1093/nar/gnh040. View

17.

Yekta S, Shih I, Bartel D . MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004; 304(5670):594-6. DOI: 10.1126/science.1097434. View

18.

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H . Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64(11):3753-6. DOI: 10.1158/0008-5472.CAN-04-0637. View

19.

Leidinger P, Keller A, Backes C, Huwer H, Meese E . MicroRNA expression changes after lung cancer resection: a follow-up study. RNA Biol. 2012; 9(6):900-10. DOI: 10.4161/rna.20107. View

20.

Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf H . Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl). 2007; 85(6):613-21. DOI: 10.1007/s00109-007-0157-6. View